Macrophage-Associated Mesenchymal Stem Cells Assume an Activated, Migratory, Pro-Inflammatory Phenotype with Increased IL-6 and CXCL10 Secretion

被引:105
作者
Anton, Kevin [1 ]
Banerjee, Debabrata [1 ,2 ]
Glod, John [1 ,3 ]
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Pharmacol, New Brunswick, NJ USA
[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Canc Inst New Jersey, New Brunswick, NJ 08903 USA
[3] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, Canc Inst New Jersey, New Brunswick, NJ 08903 USA
来源
PLOS ONE | 2012年 / 7卷 / 04期
关键词
MONOCYTE CHEMOTACTIC PROTEIN-1; BONE-MARROW; TUMOR STROMA; DELIVERY VEHICLES; TARGETED-DELIVERY; INFILTRATION; CANCER; KINASE; DIFFERENTIATION; PROLIFERATION;
D O I
10.1371/journal.pone.0035036
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mesenchymal stem cells (MSCs) exhibit tropism for sites of tissue injury and tumors. However, the influence of the microenvironment on MSC phenotype and localization remains incompletely characterized. In this study, we begin to define a macrophage-induced MSC phenotype. These MSCs secrete interleukin-6 (IL-6), CCL5, and interferon gamma-induced protein-10 (CXCL10) and exhibit increased mobility in response to multiple soluble factors produced by macrophages including IL-8, CCL2, and CCL5. The pro-migratory phenotype is dependent on activation of a c-Jun N-terminal kinase (JNK) pathway. This work begins to identify the influence of macrophages on MSC biology. These interactions are likely to play an important role in the tissue inflammatory response and may provide insight into the migratory potential of MSCs in inflammation and tissue injury.
引用
收藏
页数:10
相关论文
共 53 条
[1]  
Adamson R, 2009, J Wound Care, V18, P349
[2]   Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2 [J].
Angst, Eliane ;
Reber, Howard A. ;
Hines, Oscar J. ;
Eibl, Guido .
SURGERY, 2008, 144 (01) :57-65
[3]   Targeting the Tumor Stroma in Cancer Therapy [J].
Anton, Kevin ;
Glod, John .
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2009, 10 (02) :185-191
[4]   Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines [J].
Arenberg, DA ;
Keane, MP ;
DiGiovine, B ;
Kunkel, SL ;
Strom, SRB ;
Burdick, MD ;
Iannettoni, MD ;
Strieter, RM .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 49 (02) :63-70
[5]   Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells as Cellular Delivery Vehicles for Prodrug Gene Therapy of Glioblastoma [J].
Bak, Xiao Ying ;
Lam, Dang Hoang ;
Yang, Jingye ;
Ye, Kai ;
Wei, Esther Lee Xing ;
Lim, Sai Kiang ;
Wang, Shu .
HUMAN GENE THERAPY, 2011, 22 (11) :1365-1377
[6]   Adult mesenchymal stem cells for tissue engineering versus regenerative medicine [J].
Caplan, Arnold I. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 213 (02) :341-347
[7]   3,4-Di-O-Caffeoylquinic Acid Inhibits Angiotensin-II-Induced Vascular Smooth Muscle Cell Proliferation and Migration by Downregulating the JNK and PI3K/Akt Signaling Pathways [J].
Chiou, Wen-Fei ;
Chen, Chien-Chih ;
Wei, Bai-Luh .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2011, 2011 :1-8
[8]   Macrophages in skin injury and repair [J].
Delavary, Babak Mahdavian ;
van der Veer, Willem M. ;
van Egmond, Marjolein ;
Niessen, Frank B. ;
Beelen, Robert H. J. .
IMMUNOBIOLOGY, 2011, 216 (07) :753-762
[9]   Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells [J].
Dwyer, R. M. ;
Potter-Beirne, S. M. ;
Harrington, K. A. ;
Lowery, A. J. ;
Hennessy, E. ;
Murphy, J. M. ;
Barry, F. P. ;
O'Brien, T. ;
Kerin, M. J. .
CLINICAL CANCER RESEARCH, 2007, 13 (17) :5020-5027
[10]   Stem cell homing in musculoskeletal injury [J].
Fong, Eliza L. S. ;
Chan, Casey K. ;
Goodman, Stuart B. .
BIOMATERIALS, 2011, 32 (02) :395-409